Leigh. Good us. thank you afternoon, all for joining and you, Thank
commitment personal SeaSpine professional flexibility lives to everyone balance this to want the their dedication commitment times. the improving and tirelessly these First, I organization during they and our of I'm in of family extraordinary COVID-XX and for mission thank in the vital as their continued patients' responsibilities for pandemic. inspired by
must our and partners. virtual to to on-site distributor of support projects capabilities full facilitate to provide of wherever training our maintain combination from online our possible, continue customer daily facilities that for groups group to organizational surgeon operations and work-from-home use to tools and capacity sales a through clinical the those We work
conducting cadaveric and also as support essential the development on-site clinical product as activities for in are such labs We OR needed.
our employees to distant be to and implemented present of the safe others facilities. and at ensure guidelines safety for We physically our required through interactions have
we have and while are with adapted market teams and operations reflected an second to pandemic the new significant Consistent keeping medical throughout able improvement many the environment, continued revenue The gradual to customers device other by fully quarter. Our everyone companies, year-over-year the safe. quarter. throughout spine support initially well our to impacted followed be COVID-XX our decline, the by our
As their communicated procedures. on throughout more a quarter hospitals restrictions increasingly return implant launched spine previously as surgeries, us loosen the our the backlog our experienced begun progressed, to to and we deployment to of support we spine Many of through substantial which deferred of are surgical sets. surgeries spinal and more country have recently customers of the surgeon work they've better of more able products with
prior on recovery declined by halt April a the broad-based the declining measured X%. over to communicated, and over As increasing day than per essentially revenues meaningful as attribute and previously were June, sales sales improvement, as XX% resilient We with elective the revenue to with year, sales we performance per May state governments to on improvement, our to U.S. our just compared total sales basis just declining day In prior revenues to U.S. XX%. showed flat significant basis, more show year and began national a some year-over-year XX% by procedures. compared a revenues education mandated well programs non-urgent July, particularly the earnings are our product committed at network, increasingly that positive up as exceeded encouraged investments distributor exclusive team. made emerged May, call training provide and outstanding single hard and and U.S., robust have in core by continuing adaptability the in expanding portfolio of time work trends both revenues as expectations surgeon early quarter distributor and the and we've SeaSpine quarter dedication our of where to our second to the are The date. in in high in and our our initial in digits we the
Our and are in benefits launched immediate report newly the procedures, of on-boarded core we continue significant of recently surgeon deferred seeing backlog to customers distributors. products a
are of we for keenly of of With to and additions to in those like of revenue due However, relates particularly the footprint business further Florida. distributor the the we disruption half towards and our aware for further recent second making XXXX, and deferrable mitigate resurgence and risks. diversification targeted procedures risks states those ongoing our it elective progress COVID-XX, as are California potential Texas, to geographic
half pain our business set manufacturing innovation progress to for optimistic when that cautiously that SeaSpine to believe at service. our steadfast our we commercialization to better most are strategy our through of operational is share will aggressive essential not to growth benefit limited in to experience development debilitating second upside been to accelerated to customers. elective like the supply this milestones many deferrable only market periods half continue volumes. on our of the products orthobiologics we Irvine continue never Accordingly, surgeries focused recent the To we full out initiatives few highlight to market and provide the of May, at facility, now and the and revenue would are driving drive of belief in will We beyond, beginning update and treatment. pre-pandemic product to outlook an launch surgeries the which uninterrupted and ensure operations participate XXXX remain positioned surgical We I capacity the in guide year. In second of for we to and our the and the minutes year on of to surgery and take customer take returns operating orthobiologics next are an end, outstanding are achieve resumed innovate at seek through on spine that belief but rather has and That increasingly we time priorities. to degenerate our goals and as patients to remain
We we to able orders continue rebound manage and support year. our maintain suppliers. dialogue half of to spine constant And levels sufficient with increase the inventories through place recent been and spinal second implant the to have revenue potential in close and support with to growth procedures the collaboration and in to inventory them,
Additionally, Ray of many very with of Chain. short, Earlier our expect effectively critical to we our systems, we to our even supply more implant build In deploy all sets year, Vice with our collaborative worked as previously Biomet, third-party revenue and spinal suppliers Spinal launch higher-volume President new be Global effective growth. with which of remains to components and future procure to and suppliers. leading chain partnerships renewed we this Ray's systems of Supply efforts hired Zimmer Implant healthy. McDonagh, of more
product to spinal builds and additional procedural prioritized later implant innovation Turning toward needed of our commercialization. mix dollars new supplier investment systems year capacity set and the most XXXX. existing to satisfy We introductions and product this critical expected early and
few While product some notable we we robust did COVID-XX, our to delays a to due recent achievements. remain more by committed XXXX, the of committed in primarily new as launch firmly introductions to we evidenced experience for cadence
which NorthStar significantly a fusion. launched Cervical Fusion We for cervical expand the offerings and systems, including OCT number Systems, also new Facet posterior of procedural
launched will by it ago. launch systems energized in ultimately that the gap two XX were the big aging almost particularly last franchise as replace addressed our product NorthStar years are and We cervical
the parallel of devices. million alpha brand of the us suite interbody recently expanding effectively opportunity expandable more just under We also name, $XXX address launch allows implants of the initiated market Explorer a lordotic which and to estimated
TLIF proprietary been articulated to which hinged shown larger a launched interbody interbody Xx. with our preclinical to Topography placed sheep device also This potential the of Topography, the we disk and space. within in column anterior Reef has that the feature enables by integration is early Finally, featuring strength bone be Reef of model increase to NanoMetalene third implants
both of the latest Systems, also in full Mariner proven both of and MIS invasive and Outrigger We complex expansion the executed pathologies. platform the Mariner commercial technology a minimally launches
launch that Mariner with we invasive retractor is minimally TLIF of pedicle-based Additionally, alpha the expanded compatible our our system. recently
System we with extension deformity Stature that launched opportunities the a during line provides Daytona of season. our Lastly, us additional Deformity also Small summer
Looking second for forward, we on scheduled focused XXXX. the launches of the are many product new executing half
activities had our first development deferred earnings the of call resumed on launch we new early time of quarter the have at introductions product May. in most that and We
following: for current with expectations more the before launch some interbody the Our alpha we that a restorXD. to are of first year for developing of franchise, we the expect of include the series product the new XD-printed devices significant of end introductions upcoming the
expected Anterior System. Cervical first to foundational our launch print Shoreline is alpha be of version XD The a
robust optional from extend manage plate franchise, because a approaches, Our their and launch portfolio, of allows help believe during quarter proposition existing ever during instrumentation XD designed to include print and modular we system. anterior Reef launch the Continuing the extension Topography costs includes of our to ultimately expect us expenditures anterior more they counterpart take additional plate. modular the during TLIF, the the implant which differentiated of share. launch and efficient both ease carefully us span highly with That to cervical, alpha utilize the a alpha that systems. an the will a instrumentation locking a lateral to engagement Lateral plating successful no-profile, value application be will the Regatta designed to further quarter cervical screw system complement perhaps are NanoMetalene more as expect implant We our implant anterior next-generation line is NanoMetalene the capital use, cervical Shoreline driver fourth lumbar and to than important fourth franchise, a with new, pandemic. locking plate's with to of market In we we interbody
Topography to include these franchise, before commercial screw system will technology deformity-specific We and Mariner of that extend procedural continued address the complete thoracolumbar other the give development we modular us Shoreline efforts cases. ACS full of pedicle launch solution to end also to with expect complete a the our complex to August. In application foundational a Reef
virtual of we labs, next expect X of launch We have the able surgeon and the technology application Mariner been this and to alpha a within complete development number months. to in-person new
XD equipment, will optimistic progressing viable this long leads the of We the the of sales placement for co-marketing cycle relatively capital close of second or the Guided for with we are year. Image we've more the or Machine-Vision that many in Recognizing Surgical. these half this of opportunities received platform also are we we one on type Surgery are that sale
this valuable as financial units their purchasing due particularly Our ability budgets enabling to to likely impacts capital-efficient to the technology will COVID-XX. manner a environment of restricting of in in continue capital current are the be place hospitals
that systems want to spinal fusion. Before our to surgical a products leader as position call are SeaSpine's solutions disorders for reiterate turn in treatment engineered over I by John, providing confidence the and of in the I growing for
demand We will expect clinical superior new of patients continue results. revenue with on with customer to stay contact as for of experience pent-up that, that and and surgeons of as when we our we long-term insight disruptive distributor over With from the surgeon John work will Advisory spinal Board, partners and product turn Surgeon the customers recap COVID-XX. bring additional call accelerated and growth our impacts innovation, through in the close a John? backlog and sustained I QX emerge from financial to they lead course will to surgery responsiveness for ultimately
